Top compounds associated with response to MYO3A

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	STF-31	CTRPv2	pan-cancer	AAC	0.12	0.0004
mRNA	decitabine:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.11	0.0004
mRNA	FK866	CTRPv2	pan-cancer	AAC	0.13	0.0004
mRNA	navitoclax:piperlongumine (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.13	0.0004
mRNA	navitoclax:sorafenib (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.12	0.0004
mRNA	KPT185	CTRPv2	pan-cancer	AAC	0.13	0.0005
mRNA	NSC-207895	GDSC1000	pan-cancer	AAC	0.11	0.0005
mRNA	doxorubicin:navitoclax (2:1 mol/mol)	CTRPv2	pan-cancer	AAC	0.11	0.0005
mRNA	carboplatin:etoposide (40:17 mol/mol)	CTRPv2	pan-cancer	AAC	0.1	0.0006
mRNA	17-AAG	GDSC1000	pan-cancer	AAC	-0.11	0.0006

Download CSV